MAPK8 and ischemic stroke: JNK and p38 are important therapeutic targets in ischemic stroke, as they promote inflammatory responses, induce neuronal apoptosis, and exacerbate ischemic damage (Gao et al., 2005; Zheng et al., 2018a; Jiang et al., 2014; Barone et al., 2001).